Re-sleeping after reversal of remimazolam by flumazenil

Affiliations

¹ Division of Anesthesiology, Niigata University Graduate School of Medical and Dental Sciences, 1-757, Asahimachi-dori, Chuo ward, Niigata, 951-8510, Japan. yamatomo@med.niigata-u.ac.jp.
² Division of Anesthesiology, Niigata University Graduate School of Medical and Dental Sciences, 1-757, Asahimachi-dori, Chuo ward, Niigata, 951-8510, Japan.

Tomohiro Yamamoto et al. J Anesth. 2021 Apr.

. 2021 Apr;35(2):322.

doi: 10.1007/s00540-021-02915-x. Epub 2021 Mar 9.

¹ Division of Anesthesiology, Niigata University Graduate School of Medical and Dental Sciences, 1-757, Asahimachi-dori, Chuo ward, Niigata, 951-8510, Japan. yamatomo@med.niigata-u.ac.jp.
² Division of Anesthesiology, Niigata University Graduate School of Medical and Dental Sciences, 1-757, Asahimachi-dori, Chuo ward, Niigata, 951-8510, Japan.

No abstract available

Keywords: Flumazenil; Re-sleeping; Remimazolam; Reversal.

Comment in

What are mechanisms of re-sedation caused by remimazolam?
Godai K. Godai K. J Anesth. 2021 Jun;35(3):466. doi: 10.1007/s00540-021-02926-8. Epub 2021 Mar 22. J Anesth. 2021. PMID: 33751202 No abstract available.
A mechanism of re-sedation caused by remimazolam.
Yamamoto T, Kurabe M, Kamiya Y. Yamamoto T, et al. J Anesth. 2021 Jun;35(3):467-468. doi: 10.1007/s00540-021-02930-y. Epub 2021 Apr 6. J Anesth. 2021. PMID: 33822281 No abstract available.

1. Wesolowski AM, Zaccagnino MP, Malapero RJ, Kaye AD, Urman RD. Remimazolam: pharmacologic considerations and clinical role in anesthesiology. Pharmacotherapy. 2016;36:1021–7. - DOI
1. Doi M, Morita K, Takeda J, Sakamoto A, Yamakage M, Suzuki T. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trial. J Anesth. 2020;34:543–53. - DOI
1. Doi M, Hirata N, Suzuki T, Morisaki H, Morimatsu H, Sakamoto A. Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA Class III): results of a multicenter, randomized, double-blind, parallel-group comparative trial. J Anesth. 2020;34:491–501. - DOI
1. Masui K. Remimazolam besilate, a benzodiazepine, has been approved for general anesthesia!! J Anesth. 2020;34:479–82. - DOI
1. Hirata N, Hayamizu K, Yamakage M. How to administer remimazolam for anesthesia induction. J Anesth. 2020;34:962. - DOI